{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T06:12:01Z","timestamp":1771481521806,"version":"3.50.1"},"reference-count":25,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:00:00Z","timestamp":1771459200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Pseudoachondroplasia (PSACH) and multiple epiphyseal dysplasia-1 (EDM1) are two rare skeletal diseases that represent distinct endpoints of a continuous phenotypic spectrum with substantial clinical overlap, caused by variants in the gene coding cartilage oligomeric matrix protein (COMP).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>\n                      To summarize the clinical characteristics of PSACH\/EDM1 and variants of\n                      <jats:italic>COMP<\/jats:italic>\n                      gene, as well as to explore the correlations between them.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>PubMed, China National Knowledge Infrastructure, and Wanfang were searched for case reports and case series of patients with genetic diagnosis of PSACH\/EDM1 from the inception to 24 March 2025. The clinical characteristics and gene variants of enrolled patients were analyzed and compared to explore genotype-phenotype correlation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 830 PSACH\/EDM1 patients (471probands) harboring 224 different variants of\n                      <jats:italic>COMP<\/jats:italic>\n                      gene were enrolled from 106 articles, with missense variants accounting for the majority (80.8%). Exon 13 (183 probands, 38.9%) and type III (T3) repeat domain (413 probands, 87.7%) were the most commonly affected regions, with c.1417_1419del (p.Asp473del) being the most common hotspot variant. Compared with EDM1, PSACH manifested earlier age of onset (\n                      <jats:italic>p<\/jats:italic>\n                      &amp;lt; 0.001), shorter stature (\n                      <jats:italic>p<\/jats:italic>\n                      &amp;lt; 0.001), higher rates of lower limb deformity (\n                      <jats:italic>p<\/jats:italic>\n                      &amp;lt; 0.001), joint laxity (\n                      <jats:italic>p<\/jats:italic>\n                      = 0.041), anterior beaking of the vertebra and irregular\/flared metaphysis (\n                      <jats:italic>p<\/jats:italic>\n                      &amp;lt; 0.001), while lower rate of joint pain\/osteoarthritis (\n                      <jats:italic>p<\/jats:italic>\n                      &amp;lt; 0.001) and abnormal femoral head (\n                      <jats:italic>p<\/jats:italic>\n                      = 0.008). Missense variants in T3\u20134 and T3\u20135 were more likely to cause EDM1 (all\n                      <jats:italic>p<\/jats:italic>\n                      &amp;lt; 0.001), while those in T3\u20131 and T3\u20136 to T3\u20138 were associated with a greater frequency of PSACH (\n                      <jats:italic>p<\/jats:italic>\n                      = 0.002 to 0.023). Majority of in-frame variants were found in PSACH, as c.1417_1419del (p.Asp473del) being PSACH specific.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>PSACH exhibits more severe phenotypes than EDM1, even with phenotypic overlap. In-frame variants are more strongly associated with PSACH, as the hotspot variant p.Asp473del exclusively identified in PSACH. In contrast, missense variants in T3\u20134 and T3\u20135 show a stronger association with EDM1.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2026.1740770","type":"journal-article","created":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T05:23:07Z","timestamp":1771478587000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Genotype-phenotype correlations in PSACH\/EDM1 patients with COMP gene variants: a comprehensive review of 830 cases"],"prefix":"10.3389","volume":"17","author":[{"given":"Xiaolin","family":"Ni","sequence":"first","affiliation":[{"name":"Department of Endocrinology, Genetics and Metabolism, Beijing Children\u2019s Hospital, Capital Medical University, National Center for Children\u2019s Health","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liya","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Genetics and Metabolism, Beijing Children\u2019s Hospital, Capital Medical University, National Center for Children\u2019s Health","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weibo","family":"Xia","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Key Laboratory of Endocrinology, National Commission of Health, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Di","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Genetics and Metabolism, Beijing Children\u2019s Hospital, Capital Medical University, National Center for Children\u2019s Health","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,2,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/ng0795-330","article-title":"Pseudoachondroplasia and multiple epiphyseal dysplasia due to mutations in the cartilage oligomeric matrix protein gene","volume":"10","author":"Briggs","year":"1995","journal-title":"Nat Genet"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/ng0795-325","article-title":"Mutations in exon 17B of cartilage oligomeric matrix protein (COMP) cause pseudoachondroplasia","volume":"10","author":"Hecht","year":"1995","journal-title":"Nat Genet"},{"key":"B3","doi-asserted-by":"publisher","first-page":"3642","DOI":"10.1038\/s41467-020-17378-z","article-title":"Mutations in COMP cause familial carpal tunnel syndrome","volume":"11","author":"Li","year":"2020","journal-title":"Nat Commun"},{"key":"B4","article-title":"COMP-related pseudoachondroplasia","volume-title":"GeneReviews(","author":"Briggs","year":"1993"},{"key":"B5","article-title":"Multiple epiphyseal dysplasia, autosomal dominant","volume-title":"GeneReviews(","author":"Briggs","year":"1993"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.matbio.2018.02.023","article-title":"Cartilage oligomeric matrix protein: COMPopathies and beyond","author":"Posey","year":"2018","journal-title":"Matrix Biol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1096\/fj.08-128090","article-title":"The crystal structure of the signature domain of cartilage oligomeric matrix protein: implications for collagen, glycosaminoglycan and integrin binding","volume":"23","author":"Tan","year":"2009","journal-title":"FASEB J"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/ejhg.2014.30","article-title":"Genotype to phenotype correlations in cartilage oligomeric matrix protein associated chondrodysplasias","volume":"22","author":"Briggs","year":"2014","journal-title":"Eur J Hum Genet"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M608744200","article-title":"Cartilage oligomeric matrix protein associates with granulin-epithelin precursor (GEP) and potentiates GEP-stimulated chondrocyte proliferation","volume":"282","author":"Xu","year":"2007","journal-title":"J Biol Chem"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.180216","article-title":"COMP-assisted collagen secretion--a novel intracellular function required for fibrosis","volume":"129","author":"Schulz","year":"2016","journal-title":"J Cell Sci"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1111\/j.2042-3306.2002.tb05426.x","article-title":"Correlation of cartilage oligomeric matrix protein (COMP) levels in equine tendon with mechanical properties: a proposed role for COMP in determining function-specific mechanical characteristics of locomotor tendons","author":"Smith","year":"2002","journal-title":"Equine Vet J Suppl"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)63634-6","article-title":"Mutation (D472Y) in the type 3 repeat domain of cartilage oligomeric matrix protein affects its early vesicle trafficking in endoplasmic reticulum and induces apoptosis","volume":"163","author":"Hashimoto","year":"2003","journal-title":"Am J Pathol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M909780199","article-title":"Cartilage oligomeric matrix protein is a calcium-binding protein, and a mutation in its type 3 repeats causes conformational changes","volume":"275","author":"Chen","year":"2000","journal-title":"J Biol Chem"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.matbio.2023.03.008","article-title":"Health consequences of mutant cartilage oligomeric matrix protein and its relationship to abnormal growth and joint degeneration","volume":"119","author":"Hecht","year":"2023","journal-title":"Matrix Biol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2018.09.008","article-title":"Novel mTORC1 mechanism suggests therapeutic targets for COMPopathies","volume":"189","author":"Posey","year":"2019","journal-title":"Am J Pathol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2011.10.033","article-title":"D469del-COMP retention in chondrocytes stimulates caspase-independent necroptosis","volume":"180","author":"Coustry","year":"2012","journal-title":"Am J Pathol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddm155","article-title":"Reduced cell proliferation and increased apoptosis are significant pathological mechanisms in a murine model of mild pseudoachondroplasia resulting from a mutation in the C-terminal domain of COMP","volume":"16","author":"Pir\u00f3g-Garcia","year":"2007","journal-title":"Hum Mol Genet"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2016.12.024","article-title":"Antisense reduction of mutant COMP reduces growth plate chondrocyte pathology","volume":"25","author":"Posey","year":"2017","journal-title":"Mol Ther"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2011.10.035","article-title":"Chop (Ddit3) is essential for D469del-COMP retention and cell death in chondrocytes in an inducible transgenic mouse model of pseudoachondroplasia","volume":"180","author":"Posey","year":"2012","journal-title":"Am J Pathol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddv122","article-title":"Antioxidant and anti-inflammatory agents mitigate pathology in a mouse model of pseudoachondroplasia","volume":"24","author":"Posey","year":"2015","journal-title":"Hum Mol Genet"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2024.1399186","article-title":"Molecular diagnosis of patients with syndromic short stature identified by trio whole-exome sequencing","volume":"15","author":"Sun","year":"2024","journal-title":"Front Genet"},{"key":"B22","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1007\/s00439-002-0845-9","article-title":"Novel types of COMP mutations and genotype-phenotype association in pseudoachondroplasia and multiple epiphyseal dysplasia","volume":"112","author":"Mabuchi","year":"2003","journal-title":"Hum Genet"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.30164","article-title":"Circulating COMP is decreased in pseudoachondroplasia and multiple epiphyseal dysplasia patients carrying COMP mutations","author":"Mabuchi","year":"2004","journal-title":"Am J Med Genet A"},{"key":"B24","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.jpeds.2018.04.007","article-title":"A child with diminished linear growth and waddling gait","volume":"201","author":"Tamaro","year":"2018","journal-title":"J Pediatr"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1111\/cge.13091","article-title":"Homozygosity for a missense variant in COMP gene associated with severe pseudoachondroplasia","volume":"93","author":"Tariq","year":"2018","journal-title":"Clin Genet"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1740770\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T05:23:08Z","timestamp":1771478588000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1740770\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,19]]},"references-count":25,"alternative-id":["10.3389\/fendo.2026.1740770"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1740770","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,19]]},"article-number":"1740770"}}